Daebongls.Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Published on 14/11/2024 at 13:07
Share
Daebongls.Co.,Ltd. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was KRW 24,232.34 million compared to KRW 21,951.35 million a year ago. Net income was KRW 5,970 million compared to KRW 263.9 million a year ago. Basic earnings per share from continuing operations was KRW 545 compared to KRW 24 a year ago. Diluted earnings per share from continuing operations was KRW 545 compared to KRW 24 a year ago. Basic earnings per share was KRW 545 compared to KRW 24 a year ago.
For the nine months, sales was KRW 0.00001 million compared to KRW 0.00002 million a year ago. Net income was KRW 8,199.41 million compared to KRW 2,304.79 million a year ago. Basic earnings per share from continuing operations was KRW 749 compared to KRW 211 a year ago. Diluted earnings per share from continuing operations was KRW 749 compared to KRW 211 a year ago. Basic earnings per share was KRW 749 compared to KRW 211 a year ago.
Daebongls. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The Company operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The Company distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.
